Product Images Topiramate

This is a graph that displays the cumulative rates for time to the first seizure. The data is comparing two groups, one group of 234 individuals taking 50mg/day of topiramate and the other group of 236 individuals taking 400mg/day of topiramate. The graph shows that the two groups have significantly different rates of experiencing a seizure, with a p-value of 0.0002. The x-axis displays the time in days and ranges from 0 to 400, while the y-axis shows the cumulative rate percentage and ranges from 0 to 100.*

This text appears to be a table showing the change in average monthly migraine period rate from baseline to double-blind phase across different treatment groups (placebo, topiramate at 50mg/day, 100mg/day, and 200mg/day). The table includes counts of participants in each group (N values) and a significant difference in migraine rate is noted with asterisks denoting the level of significance. A description of what study this table is referring to and any further context is not available.*

This is a medication called Topiramate that comes in the form of 25 mg tablets packaged by Remedy Repack Inc. Its National Drug Code (NDC) is 70518-0233-00 and it is manufactured by Zydus Pharm in Pennington, NJ. The medication should be kept out of reach of children and stored at a temperature between 20-25°C (68-77°F) with excursions permitted of 15-30°C (59-86°F). The prescription must be used according to instructions provided in the package insert.*